Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-971"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-971"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I voted for this important resolution which aims to enable patients to be better informed on the medicines they are prescribed. There are considerable problems with the current legal framework and the situation within Europe when it comes to patients’ access to information on prescription-only medicine. The differences in interpretations of the directive by the Member States give patients in different parts of Europe different access to high quality and comprehensive information on pharmaceuticals. In some Member States, patients lack easy access to even the most basic information about the pharmaceuticals they are prescribed. Given the different interpretation of the directive in the Member States, I feel there needs to be increased clarity in the provisions so that all EU citizens are able to receive the information they require in connection with pharmaceuticals. The amendments adopted by the European Parliament also ensure that information on prescribed medicine is only given to the public through specific communication channels, including specialised and certified websites safeguarding patients’ interests and aiming to limit advertisement opportunities for the pharmaceutical companies."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples